Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ADAM metallopeptidase domain 17 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | Blood coagulation inhibitor Disintegrin | Get druggable targets OG5_132656 | All targets in OG5_132656 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_132656 | All targets in OG5_132656 |
Schistosoma japonicum | ko:K06059 a disintegrin and metalloproteinase domain 17, putative | Get druggable targets OG5_132656 | All targets in OG5_132656 |
Echinococcus granulosus | adam 17 protease | Get druggable targets OG5_132656 | All targets in OG5_132656 |
Schistosoma mansoni | ADAM17 peptidase (M12 family) | Get druggable targets OG5_132656 | All targets in OG5_132656 |
Echinococcus multilocularis | Blood coagulation inhibitor, Disintegrin | Get druggable targets OG5_132656 | All targets in OG5_132656 |
Echinococcus multilocularis | adam 17 protease | Get druggable targets OG5_132656 | All targets in OG5_132656 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Disintegrin family protein | ADAM metallopeptidase domain 17 | 824 aa | 724 aa | 27.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0129 | 0.065 | 0.5 |
Treponema pallidum | cell division protein FtsZ | 0.0355 | 0.6887 | 0.5 |
Schistosoma mansoni | ADAM17 peptidase (M12 family) | 0.0223 | 0.324 | 1 |
Mycobacterium ulcerans | cell division protein FtsZ | 0.0355 | 0.6887 | 0.5 |
Echinococcus granulosus | adam 17 protease | 0.0245 | 0.3852 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.011 | 0.0126 | 0.0651 |
Schistosoma mansoni | hypothetical protein | 0.0191 | 0.2355 | 0.7269 |
Echinococcus multilocularis | Blood coagulation inhibitor, Disintegrin | 0.014 | 0.0953 | 0.2942 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0129 | 0.065 | 0.5 |
Echinococcus granulosus | geminin | 0.0191 | 0.2355 | 0.6114 |
Brugia malayi | Cell division protein ftsZ | 0.0175 | 0.1931 | 1 |
Echinococcus granulosus | Blood coagulation inhibitor Disintegrin | 0.014 | 0.0953 | 0.2474 |
Loa Loa (eye worm) | hypothetical protein | 0.0129 | 0.065 | 0.0531 |
Schistosoma mansoni | hypothetical protein | 0.0129 | 0.065 | 0.2007 |
Wolbachia endosymbiont of Brugia malayi | cell division protein FtsZ | 0.0355 | 0.6887 | 0.5 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0129 | 0.065 | 0.2007 |
Echinococcus multilocularis | adam 17 protease | 0.0223 | 0.324 | 1 |
Brugia malayi | Kringle domain containing protein | 0.0129 | 0.065 | 0.3366 |
Onchocerca volvulus | 0.0129 | 0.065 | 0.5 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0129 | 0.065 | 0.5 |
Brugia malayi | Cell division protein ftsZ | 0.017 | 0.1796 | 0.9302 |
Schistosoma mansoni | hypothetical protein | 0.0191 | 0.2355 | 0.7269 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0129 | 0.065 | 0.0531 |
Mycobacterium tuberculosis | Cell division protein FtsZ | 0.0355 | 0.6887 | 0.5 |
Echinococcus multilocularis | geminin | 0.0191 | 0.2355 | 0.7269 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.011 | 0.0126 | 0.0651 |
Brugia malayi | Protein kinase domain containing protein | 0.0129 | 0.065 | 0.3366 |
Mycobacterium leprae | cell division protein FtsZ | 0.0355 | 0.6887 | 0.5 |
Toxoplasma gondii | kringle domain-containing protein | 0.0129 | 0.065 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0129 | 0.065 | 0.5 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0129 | 0.065 | 0.1688 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.